Literature DB >> 31412368

[Treatment Preferences of Depressed Primary Care Patients].

Lara Backhaus1, Alexander Pabst1, Margit Löbner1, Steffi Riedel-Heller1, Melanie Luppa1.   

Abstract

OBJECTIVE: Assessment of patients' preferences regarding depression treatment using a ranking approach.
METHODS: 641 primary care patients (mean age 43.9 years) ranked their primary preference for depression treatment out of 9 options. Logistic Regression analyses were used to determine factors associated with the most prioritized treatment options.
RESULTS: The most frequently prioritized treatment options were psychotherapy (30 %), combination treatment of psychotherapy and drug treatment (18.4 %) and sole drug treatment (15.4 %). 12.3 % of women prioritized alternative therapy options.
CONCLUSION: Patients with depression report individually different treatment preferences. These findings underline the importance of elucidating patients' preferences within a shared decision making process as recommended by treatment guidelines. There is a need of evidence-based information on the role of alternative therapies in the context of depression treatment. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 31412368     DOI: 10.1055/a-0961-1628

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  2 in total

1.  Internet-Based Cognitive Behavior Therapy Only for the Young? A Secondary Analysis of a Randomized Controlled Trial of Depression Treatment.

Authors:  Alexander Pabst; Margrit Löbner; Janine Stein; Melanie Luppa; Anette Kersting; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  Front Psychiatry       Date:  2020-07-24       Impact factor: 4.157

2.  What Comes after the Trial? An Observational Study of the Real-World Uptake of an E-Mental Health Intervention by General Practitioners to Reduce Depressive Symptoms in Their Patients.

Authors:  Margrit Löbner; Janine Stein; Melanie Luppa; Markus Bleckwenn; Anja Mehnert-Theuerkauf; Steffi G Riedel-Heller
Journal:  Int J Environ Res Public Health       Date:  2022-05-19       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.